… drug specificity in the targeting of TNBC. In this paper, LHRH-conjugated prodigiosin and
LHRH-conjugated paclitaxel were studied as model cancer drugs. These were synthesized by …

… local concentrations of the targeting moiety and the drug, … discussed studies, LHRH-conjugated
dextran nanoparticles … be utilized as self-therapeutic agents as well as nanocarriers…

… and clinical impingement of the peptide is at both the diagnostic as well as therapeutic levels
[50]. Receptor mediated in vivo scintigraphy employs localization of radioactive molecule …

… localization studies, which highlighted the higher tumor accumulation ability of the LHRH-conjugated …
out that the use of a combination of drugs DTX and QU gives enhanced anticancer …

… targeted administration of anticancer drugs, thus opening up the possibility of a drug delivery
system with precise control and targeting … improved efficacy for prostate cancer therapy. …

… of CDDP-loaded LHRH-conjugated targeted and non-targeted … drug release behavior,
prolonged blood circulation and enhanced tumor localization, the CDDP-loaded LHRH-targeted …

… is the poor accessibility of therapeutic agents, especially chemotherapeutic agents, to cancer
… addressed by targeting therapeutic agents exclusively to cancer cells via agents designed …

… The in vivo anti-tumor activity of the therapeutic agents were assessed on mice bearing PC-…
to the targeting features of [DLys 6 ]-LHRH-MTX that allow for better localization of treatment …

… cells, ∗∗ p < 0.01), demonstrating that the LHRH conjugated nanoparticles were
recognized by LHRH receptors on the surface of 4T1 cells and internalized through receptor-mediated …

… -LHRH conjugated PEG 5k -Cys 4 -L 8 -CA 8 telodendrimer, which will facilitate the precise
delivery of therapeutic drugs into breast cancer cells through specific … co-localization method. …